Home Medicine Cancer during pregnancy – clinical characteristics, treatment outcomes and prognosis for mothers and infants
Article
Licensed
Unlicensed Requires Authentication

Cancer during pregnancy – clinical characteristics, treatment outcomes and prognosis for mothers and infants

  • Katarina Jeremic EMAIL logo , Aleksandar Stefanovic , Jelena Dotlic , Sasa Kadija , Olivera Kontic , Miroslava Gojnic , Jelena Jeremic and Vesna Kesic
Published/Copyright: February 21, 2017

Abstract

Objective:

To assess which obstetrical characteristics and treatment improved outcomes and prognosis of pregnant women with malignancy.

Methods:

A prospective study, undertaken between 2005 and 2014, involving 35 pregnant women who were diagnosed with malignant tumors during pregnancy. Patients were followed-up for 1 year after delivery. The pregnancy course and outcome and parameters that could influence the condition of mother and fetus were evaluated.

Results:

Most malignancies were hematological, diagnosed in the second trimester and treated with combined therapy (surgery/adjuvant) after pregnancy. Most fetuses were in good state throughout pregnancy, but were delivered by caesarean section (CS) before term. Adjuvant therapy during pregnancy mostly caused transitory deterioration of fetal conditions. The majority of both mothers and infants were in a good state 12 months postpartum, although numerous mothers were still ill and on therapy. Surviving pregnancy and preventing tumors progression during pregnancy were the best predictors of mothers’ future condition (P=0.022). High birthweight and term delivery were the most important factors for good outcome of the infants (P=0.001).

Conclusions:

If the tumor is not progressing, pregnancy should be continued as long as possible to obtain adequate birthweight of the infant. Second trimester surgery is safe, while other therapies should preferably be applied after delivery.


Corresponding author: Katarina Jeremic, MD, PhD, Associate Professor, Clinic of Obstetrics and Gynecology, Clinical Centre of Serbia, Dr Koste Todorovica 26, Belgrade, Serbia; and Faculty of Medicine, University of Belgrade, Dr Subotica 8, Belgrade, Serbia, Tel.: +381 11 361 5592, Fax: +381 11 361 5603

Acknowledgment

This work was supported by research Grant No 41023 for period 2011–2015 issued by the Ministry of Science of the Republic of Serbia.

Author’s statement

  1. Conflict of interest: Authors state no conflict of interest.

  2. Material and methods: Informed consent: Informed consent has been obtained from all individuals included in this study.

  3. Ethical approval: The research related to human subject use has complied with all the relevant national regulations, and institutional policies, and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

References

[1] Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancy-associated cancer in Denmark, 1977–2006. Obstet Gynecol. 2013;122:608–17.10.1097/AOG.0b013e3182a057a2Search in Google Scholar

[2] Karimi-Zarchi M, Ezabadi MG, Hekmatimoghaddam S, Mortazavizade M, Taghipour S, Vahidfar M, et al. Cancer in pregnancy: a 10-year experience in Shahid Sadoughi hospital, Yazd, Iran. Int J Biomed Sci. 2013;9:168–73.10.59566/IJBS.2013.9168Search in Google Scholar

[3] Teran-Porcayo MA, Gomez-Del Castillo-Rangel AC, Barrera-Lopez N, Zeichner-Gancz I. Cancer during pregnancy: 10-year experience at a regional cancer reference center in Mexico. Med Oncol. 2008;25:50–3.10.1007/s12032-007-0020-1Search in Google Scholar

[4] Liu Y, Liu Y, Wang Y, Chen X, Chen H, Zhang J. Malignancies associated with pregnancy: an analysis of 21 clinical cases. Ir J Med Sci. 2015;184:175–81.10.1007/s11845-014-1083-6Search in Google Scholar

[5] Lee Y, Roberts C, Dobbins T, Stavrou E, Black K, Morris J, et al; Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. Br J Obstet Gynaecol. 2012;119:1572–82.10.1111/j.1471-0528.2012.03475.xSearch in Google Scholar

[6] Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V, Society of Obsteritcians and Gynaecologists of Canada. Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can. 2013;35:263–80.10.1016/S1701-2163(15)30999-3Search in Google Scholar

[7] Panchani R, Varma T, Goyal A, Tripathi S. Parathyroid carcinoma masquerading as morning sickness in pregnancy. Indian J Endocrinol Metab. 2013;17:S198–200.10.4103/2230-8210.119570Search in Google Scholar PubMed PubMed Central

[8] Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, Van Calsteren K, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24:394–403.10.1097/IGC.0000000000000062Search in Google Scholar PubMed

[9] Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N, on behalf of the ESMO Guidelines Working Group. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:sv266–73.10.1093/annonc/mdq198Search in Google Scholar PubMed

[10] Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al.; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24: S160–70.10.1093/annonc/mdt199Search in Google Scholar PubMed

[11] Han SN, Kesic VI, Van Calsteren K, Petkovic S, Amant F; ESGO ‘Cancer in Pregnancy’ Task Force. Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol. 2013;167:18–23.10.1016/j.ejogrb.2012.10.026Search in Google Scholar PubMed

[12] Bulas D, Egloff A. Benefits and risks of MRI in pregnancy. Semin Perinatol. 2013;37:301–4.10.1053/j.semperi.2013.06.005Search in Google Scholar

[13] Leath CA 3rd, Bevis KS, Numnum TM, Ramsey PS, Huh WK, Straughn JM Jr. Comparison of operative risks associated with radical hysterectomy in pregnant and nonpregnant women. J Reprod Med. 2013;58:279–84.Search in Google Scholar

[14] Peng P, Zhu L, Lang JH, Liu ZF, Sun DW, Leng JH. Clinical analysis of laparoscopic surgery for ovarian masses under different conditions during the second trimester. Chin Med J. 2013;126:3325–8.10.3760/cma.j.issn.0366-6999.20123553Search in Google Scholar

[15] Yun NR, Park JW, Hyun MK, Park JH, Choi SJ, Song E. Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy. Obstet Gynecol Sci. 2013;56:121–5.10.5468/OGS.2013.56.2.121Search in Google Scholar

[16] De Haan J, Vandecaveye V, Han SN, Van de Vijvek KK, Amant F. Difficulties with diagnosis of malignancies in pregnancy. Best Practice Res Clin Obstet Gynecol. 2016;33:19–32.10.1016/j.bpobgyn.2015.10.005Search in Google Scholar

[17] Akhter N, Habib A. Successful pregnancy outcome with coexisting primary epithelial ovarian carcinoma. Mymensingh Med J. 2013;22:599–602.Search in Google Scholar

[18] Marret H, Lhome C, Lecuru F, Canis M, Leveque J, Golfier F, et al. Guidelines for the management of ovarian cancer during pregnancy. Eur J Obst Gynecol Reprod Biol. 2010;149:18–21.10.1016/j.ejogrb.2009.12.001Search in Google Scholar

[19] Genin AS, Antoine M, Aractingi S, Rouzier R. Pregnancy stimulates tumor angiogenesis in breast carcinoma. Anticancer Res. 2014;34:125–31.Search in Google Scholar

[20] Nomura RM, Igai AM, Faciroli NC, Aguiar IN, Zugaib M. Maternal and perinatal outcomes in pregnant women with leukemia. Rev Bras Ginecol Obstet. 2011;33:174–81.Search in Google Scholar

[21] Swierczewski A, Pasinski J, Estemberg D, Kus E, Brzozowska M, Kuzmecka-Matuszewska J, et al. Pregnancy and delivery in a patient with non-Hodgkin lymphoma – a case report. Ginekol Pol. 2012;83:57–61.Search in Google Scholar

[22] Bachanova V, Connors JM. Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 2013;8:211–7.10.1007/s11899-013-0163-4Search in Google Scholar

[23] Aviles A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Int J Cancer. 2012;131:2678–83.10.1002/ijc.27560Search in Google Scholar

[24] Saha SK, Mandal T, Saha A. Pregnancy with carcinoma cervix. J Obstet Gynaecol India 2012;62:38–9.10.1007/s13224-013-0377-3Search in Google Scholar

[25] Sljivancanin D, Kesic V, Tulic L, Dotlic J. Assessment of the natural course and treatment of premalignant uterine cervical lesions in pregnancy. Srp Arh Celok Lek. 2013;141: 192–7.10.2298/SARH1304192SSearch in Google Scholar

[26] Rovera F, Chiappa C, Coglitore A, Baratelli GM, Fachinetti A, Marelli M, et al. Management of breast cancer during pregnancy. Int J Surg. 2013;11:S64–8.10.1016/S1743-9191(13)60020-5Search in Google Scholar

[27] Madaras L, Kovacs KA, Szasz AM, Kenessey I, Tokes AM, Szekely B, et al. Clinicopathological features and prognosis of pregnancy associated breast cancer – a matched case control study. Pathol Oncol Res. 2014;20:581–90.10.1007/s12253-013-9735-9Search in Google Scholar PubMed

[28] Jhaveri MB, Driscoll MS, Grant-Kells J. Melanoma in pregnancy. Clin Obstet Gynecol. 2011;54:537–45.10.1097/GRF.0b013e318236e18bSearch in Google Scholar

[29] Al-Ibrahim A, Parrish J, Dunn E, Swallow C, Maxwell C. Pregnancy and maternal outcomes in women with prior or current gastrointestinal malignancies. J Obstet Gynaecol Can. 2014;36:34–41.10.1016/S1701-2163(15)30681-2Search in Google Scholar

[30] Attraplsi S, Shobar RM, Lamzabi I, Abraham R. Gallbladder carcinoma in a pregnant patient with Crohn’s disease complicated with gallbladder involvement. World J Gastrointest Oncol. 2013;5:29–33.10.4251/wjgo.v5.i2.29Search in Google Scholar PubMed PubMed Central

[31] Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010;33:221–8.10.1097/COC.0b013e3181a44ca9Search in Google Scholar PubMed

[32] Ji YI, Kim KT. Gynecologic malignancy in pregnancy. Obstet Gynecol Sci. 2013;56:289–300.10.5468/ogs.2013.56.5.289Search in Google Scholar PubMed PubMed Central

Received: 2016-6-18
Accepted: 2017-1-12
Published Online: 2017-2-21
Published in Print: 2018-1-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. The assessment of labor: a brief history
  4. Original articles – Obstetrics
  5. The combined exposure to intra-amniotic inflammation and neonatal respiratory distress syndrome increases the risk of intraventricular hemorrhage in preterm neonates
  6. Uterine artery Doppler pulsatility index at 11–38 weeks in ICSI pregnancies with egg donation
  7. Violence before pregnancy and the risk of violence during pregnancy
  8. Cancer during pregnancy – clinical characteristics, treatment outcomes and prognosis for mothers and infants
  9. The effect of attending a prenatal childbirth preparedness course on labor duration and outcomes
  10. Serum fibrinogen levels could be an index of successful use of balloon tamponade in postpartum hemorrhage
  11. Impact factors on cervical dilation rates in the first stage of labor
  12. Feasibility and acceptability of text messaging to support antenatal healthcare in Iraqi pregnant women: a pilot study
  13. Clinical characteristics and outcome of twin pregnancies complicated by single intrauterine death
  14. Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: a single center review
  15. The association between pre-pregnancy obesity and screening results of depression for all trimesters of pregnancy, postpartum and 1 year after birth: a cohort study
  16. Original articles – Fetus
  17. Causes of intrauterine fetal death are changing in recent years
  18. Original articles – Newborn
  19. Proactive approach at the limits of viability improves the short-term outcome of neonates born after 23 weeks’ gestation
  20. Letter to the Editor
  21. Exact days of gestation necessary for infants at borderline viability: reply to Proactive approach at the limits of viability improves the short-term outcome of neonates born after 23weeks’ gestation. P. Šimják, J. Smíšek, M. Koucký, T. Lamberská, R. Plavka and Z. Hájek. J Perinat Med 2017
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2016-0212/html
Scroll to top button